# Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

> **NCT05917405** · PHASE2 · RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 302 (estimated)

## Conditions studied

- Acute Myeloid Leukemia in Remission

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Busulfan
- **DRUG:** ATG
- **DRUG:** Clofarabine

## Key facts

- **NCT ID:** NCT05917405
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-14
- **Primary completion:** 2028-09-14
- **Final completion:** 2028-09-14
- **Target enrollment:** 302 (ESTIMATED)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05917405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05917405, "Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05917405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*